Moxifloxacin Krka

Moxifloxacin, the active ingredient in Moxifloxacin Krka, is a fluoroquinolone antibiotic presented as a tablet for oral use. It treats a range of bacterial infections, including community‑acquired pneumonia, acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and skin and soft‑tissue infections in adult patients.

GNH USA supplies Moxifloxacin Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches for global distribution.

Moxifloxacin is a fluoroquinolone antibiotic indicated for several bacterial infections affecting the respiratory tract and skin.

Community‑acquired bacterial pneumonia: eradicates the causative pathogens and improves clinical symptoms. Acute bacterial sinusitis: reduces sinus inflammation and clears infection. Acute bacterial exacerbation of chronic bronchitis: shortens the duration of exacerbation and restores lung function. Skin and soft‑tissue infections: eliminates susceptible bacteria and promotes wound healing.

Moxifloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Diarrhea - Headache - Dizziness - Rash

Serious or Rare Side Effects: - Tendon rupture or inflammation - QT interval prolongation leading to arrhythmia - Severe allergic reactions such as anaphylaxis - Clostridioides difficile‑associated colitis

Before prescribing moxifloxacin, clinicians should consider several precautionary measures to minimize risk. - Assess renal and hepatic function: adjust therapy if impairment is present. - Monitor for tendon pain or swelling: discontinue if signs of tendonitis appear. - Avoid concomitant use with other QT‑prolonging agents: increased risk of cardiac arrhythmias. - Use with caution in patients with a history of seizures: may lower seizure threshold. - Review anticoagulant therapy: warfarin may require INR monitoring. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Moxifloxacin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids or supplements containing magnesium, aluminum, calcium, or iron: reduce absorption of moxifloxacin. - Drugs that prolong the QT interval (e.g., macrolide antibiotics, antiarrhythmics): increase risk of cardiac arrhythmias. - Warfarin: may enhance anticoagulant effect and raise INR.

Moderate Interactions (Monitor Closely): - Oral contraceptives: efficacy may be decreased, consider alternative contraception. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase central nervous system side effects.